Cerebral Palsy (CP) is a neurological disorder that affects movement, posture, and coordination. It is caused by damage to the developing brain, usually before or during birth. CP is a lifelong condition that can range from mild to severe, and can affect physical, cognitive, and social functioning.
The therapeutic area for CP is focused on improving the quality of life for those affected. Treatment options include physical, occupational, and speech therapy, as well as medications, assistive devices, and surgery. There is also a focus on providing support and education to families and caregivers.
Companies in the CP market include AbbVie, Biogen, GlaxoSmithKline, Novartis, Pfizer, and Sanofi. These companies are involved in the development of medications, therapies, and assistive devices to help those with CP. Show Less Read more
